SS
CAPR icon

SBI Securities’s Capricor Therapeutics CAPR Stock Holding History

SBI Securities’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.8K Sell
2,815
-2,128
-43% -$64.5K ﹤0.01% 1062
2026
Q1 		$150K Buy
4,943
+4,809
+3,589% +$128K ﹤0.01% 719
2025
Q4 		$3.87K Buy
134
+67
+100% +$875 ﹤0.01% 2126
2025
Q3 		$483 Sell
67
-36
-35% -$265 ﹤0.01% 2983
2025
Q2 		$1.02K Buy
103
+99
+2,475% +$1.05K ﹤0.01% 2669
2025
Q1 		$38 Buy
4
+2
+100% +$28 ﹤0.01% 3712
2024
Q4 		$28 Buy
+2
New +$35 ﹤0.01% 3761

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SBI Securities's CAPR Position: Q2 2026 in Review

SBI Securities reduced its Capricor Therapeutics (CAPR) stake by 43% in Q2 2026, selling an estimated $64.5K and leaving 2,815 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

SBI Securities first reported a position in CAPR in Q4 2024 and has held it in 7 quarters since. The position peaked at $150K in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • SBI Securities held 2,815 shares of Capricor Therapeutics worth $67.8K as of Q2 2026.
  • SBI Securities sold 2,128 Capricor Therapeutics shares in Q2 2026, an estimated $64.5K.
  • Capricor Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1062 holding.
  • SBI Securities first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Capricor Therapeutics position peaked at $150K in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.